Physician profile
Jack E Russo
NPI 1689990616
$1,310.04
in general payments reported to CMS, 2019-2025
10 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.12 · 2021: $55.71 · 2022: $296 · 2023: $79.84 · 2024: $468 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $452.78 | 2022-2025 | Pteye Parathyroid Detection System, Stealthstation S8 Platform, Propel |
| Cambridge Interventional LLC | $328.63 | 2024 | Crf |
| Stryker Corporation | $238.78 | 2022-2023 | Scopis Ent |
| Optinose US, INC. | $83.86 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $50.50 | 2024 | Ryaltris |
| Neurent Medical Limited | $40.31 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Welch Allyn | $40.28 | 2021 | |
| Integra Lifesciences Corporation | $34.26 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Smith+Nephew, INC. | $21.31 | 2024 | |
| Intersect Ent, INC. | $19.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.